1. 1. Edition F. Diagnostic and statistical manual of mental disorders. Am Psychiatric Assoc. 2013;21.
2. 2. Lopez-Ibor Jr JJ, Saiz J, Cottraux J, Note I, Vinas R, Bourgeois M, Hernandez M, Gomez-Perez JC. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. European Neuropsychopharmacology. 1996 May 1;6(2):111-8. [
DOI]
3. 3. Mataix-Cols D, Sànchez-Turet M, Vallejo J. A Spanish version of the Padua Inventory: Factor structure and psychometric properties. Behavioural and Cognitive Psychotherapy. 2002;30(1):25.
4. 4. Gwilliam P, Wells A, Cartwright‐Hatton S. Dose meta‐cognition or responsibility predict obsessive–compulsive symptoms: a test of the metacognitive model. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice. 2004 Mar;11(2):137-44. [
DOI]
5. 5. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. Journal of consulting and clinical psychology. 1997 Feb;65(1):44. [
DOI]
6. 6. Rassin E. The contribution of thought–action fusion and thought suppression in the development of obsession-like intrusions in normal participants. Behaviour Research and Therapy. 2001 Sep 1;39(9):1023-32. [
DOI]
7. 7. Rassin E, Koster E. The correlation between thought–action fusion and religiosity in a normal sample. Behaviour Research and Therapy. 2003 Mar 1;41(3):361-8. [
DOI]
8. 8. Myers SG, Fisher PL, Wells A. An empirical test of the metacognitive model of obsessive-compulsive symptoms: fusion beliefs, beliefs about rituals, and stop signals. Journal of anxiety disorders. 2009 May 1;23(4):436-42. [
DOI]
9. 9. Rassin E, Merckelbach H, Muris P, Spaan V. Thought–action fusion as a causal factor in the development of intrusions. Behaviour research and therapy. 1999 Mar 1;37(3):231-7. [
DOI]
10. 10. Van Oppen P, De Haan E, Van Balkom AJ, Spinhoven P, Hoogduin K, Van Dyck R. Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behaviour research and therapy. 1995 May 1;33(4):379-90. [
DOI]
11. 11. ME F, JS A, J KM, T LJ, B FE. Effectiveness of Exposure and Titular Prevention for Obsessive-Compulsive Disorder : Randomized Compared with Nonrandomized Samples. Journal of Consulting and Clinical Psychology. 2000:594-602. [
Article]
12. 12. Eddy KT, Dutra L, Bradley R, Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clinical psychology review. 2004 Dec 1;24(8):1011-30. [
DOI]
13. 13. Steketee G, Frost RO, Cohen I. Beliefs in obsessive-compulsive disorder. Journal of anxiety disorders. 1998 Nov 1;12(6):525-37. [
DOI]
14. 14. Abramowitz JS, Jacoby RJ. Obsessive-compulsive and related disorders: A critical review of the new diagnostic class. Annual Review of Clinical Psychology. 2015 Mar 28;11:165-86. [
DOI]
15. 15. Wells A, Gwilliam P, Cartwright-Hatton S. The thought fusion instrument (unpublished self-report scale). UK: University of Manchester. 2001.
16. 16. Emmelkamp PM, Aardema A. Metacognition, specific obsessive–compulsive beliefs and obsessive–compulsive behaviour. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice. 1999 May;6(2):139-45. [
DOI]
17. 17. Fisher PL, Wells A. How effective are cognitive and behavioral treatments for obsessive–compulsive disorder? A clinical significance analysis. Behaviour research and therapy. 2005 Dec 1;43(12):1543-58. [
DOI]
18. 18. Fisher PL, Wells A. Metacognitive therapy for obsessive–compulsive disorder: A case series. Journal of behavior therapy and experimental psychiatry. 2008 Jun 1;39(2):117-32. [
DOI]
19. 19. Gwilliam P, Wells A, Cartwright‐Hatton S. Dose meta‐cognition or responsibility predict obsessive–compulsive symptoms: a test of the metacognitive model. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice. 2004 Mar;11(2):137-44. [
DOI]
20. 20. Shafran R, Rachman S. Thought-action fusion: A review. Journal of Behavior Therapy and Experimental Psychiatry. 2004 Jun 1;35(2):87-107. [
DOI]
21. 21. Khoramdel K, Rabiee M, Molavi H, Neshatdoost HT. Psychometric properties of thought fusion instrument (TFI) in students. Iranian Journal of psychiatry and clinical psychology. 2010 Apr 10;16(1):74-8. [Persian]
22. 22. Khoramdel K. Effect of Wells’ metacognitive therapy on thought fusion in patients with obsessive compulsive disorder. Journal of Fundamentals of Mental Health. 2010 Mar 21;12(45):9-400. [
DOI]
23. 23. Simons M, Schneider S, Herpertz-Dahlmann B. Metacognitive therapy versus exposure and response prevention for pediatric obsessive-compulsive disorder. Psychotherapy and psychosomatics. 2006;75(4):257-64.
24. 24. Tibi L, van Oppen P, van Balkom AJ, Eikelenboom M, Hendriks GJ, Anholt GE. The relationship between cognitions and symptoms in obsessive-compulsive disorder. Journal of affective disorders. 2018 Jan 1;225:495-502. [
DOI]
25. 25. Myers SG, Grøtte T, Haseth S, Guzey IC, Hansen B, Vogel PA, Solem S. The role of metacognitive beliefs about thoughts and rituals: A test of the metacognitive model of obsessive-compulsive disorder in a clinical sample. Journal of Obsessive-Compulsive and Related Disorders. 2017 Apr 1;13:1-6. [
DOI]
26. 26. Hansmeier J, Exner C, Rief W, Glombiewski JA. A test of the metacognitive model of obsessive-compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders. 2016 Jul 1;10:42-8. [
DOI]
27. 27. van der Heiden C, van Rossen K, Dekker A, Damstra M, Deen M. Metacognitive therapy for obsessive–compulsive disorder: A pilot study. Journal of Obsessive-Compulsive and Related Disorders. 2016 Apr 1;9:24-9. [
DOI]
